Immix Biopharma, Inc (IMMX) insider trading

Every open-market stock purchase and sale by Immix Biopharma, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Gabriel S Morris (CFO), $5.1K, 10 months ago.

Last 12 months: insiders bought $10K (2 buys) and sold $0 (0 sales). Last close $7.93 on Jun 4, 2026.

Recent IMMX insider trades

DateInsiderTradeValue
May 22, 2026Yekaterina Chudnovsky (Director)Bought (not open market)—
May 22, 2026Carey Ng (Director)Bought (not open market)—
May 22, 2026Nancy T Chang (Director)Bought (not open market)—
May 22, 2026Carey Ng (Director)Bought (not open market)—
May 22, 2026Helen C. Adams (Director)Bought (not open market)—
May 22, 2026Helen C. Adams (Director)Bought (not open market)—
May 22, 2026Jane Buchan (Director)Bought (not open market)—
May 22, 2026Gabriel S Morris (CFO)Bought (not open market)—
May 22, 2026Magda Marquet (Director)Bought (not open market)—
May 22, 2026Jane Buchan (Director)Bought (not open market)—
May 22, 2026Magda Marquet (Director)Bought (not open market)—
May 22, 2026Nancy T Chang (Director)Bought (not open market)—
May 22, 2026Ilya M Rachman (CEO)Bought (not open market)—
May 22, 2026Jason Hsu (Director)Bought (not open market)—
May 22, 2026Jason Hsu (Director)Bought (not open market)—
May 22, 2026Yekaterina Chudnovsky (Director)Bought (not open market)—
Dec 10, 2025Gabriel S Morris (CFO)Bought$5.1K
Dec 10, 2025Ilya M Rachman (CEO)Bought$5K
Dec 8, 2025Gabriel S Morris (CFO)Bought (not open market)$125K
Dec 8, 2025Gabriel S Morris (CFO)Bought (not open market)—
Dec 8, 2025Gabriel S Morris (CFO)Bought (not open market)—
Nov 21, 2025Nancy T Chang (Director)Bought (not open market)—

Who's trading IMMX

Get free alerts when an insider at Immix Biopharma, Inc files a new trade →